ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Sep 4, 2014
Insider Transaction Report
Form 4
KAPLAN LESTER J PH D
Director
Transactions
- Exercise/Conversion
Stock option (right to buy)
2014-09-02−57,692→ 0 totalExercise: $1.30Exp: 2020-06-10→ Common Stock (57,692 underlying) - Exercise/Conversion
Common Stock
2014-09-02$1.30/sh+57,692$75,000→ 66,192 total - Sale
Common Stock
2014-09-02$26.76/sh−57,692$1,543,838→ 8,500 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2013.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following June 11, 2010.